This Week in PLOS NTDs and PLOS Pathogens: Dengue and Pregnancy; Protection Against B. pseudomallei; Bacterial VOC Diagnostics; H1N1 Antigenic Change; and more

Karagiannis-Voules D-A, Scholte RGC, Guimarães LH, Utzinger J, Vounatsou P (2013) Bayesian Geostatistical Modeling of Leishmaniasis Incidence in Brazil. PLoS Negl Trop Dis 7(5): e2213. doi:10.1371/journal.pntd.0002213

New articles publishing in PLOS Neglected Tropical Diseases:

The occurrence of dengue fever and dengue hemorrhagic fever has increased in Brazil, in part due to the simultaneous circulation of DENV-1, DENV-2 and DENV-3, with severe outcomes being reported with some pregnant patients. Dr. Carolina Machado and colleagues analyzed available data compiled between 2007 and 2008 and discovered that pregnant women are 3-4 times more prone to developing severe dengue symptoms than non-pregnant patients.

Understanding the transmission of leishmaniasis in Brazil is essential to prevention and control efforts. Dr. Dimitrios-Alexios Karagiannis-Voules and colleagues used reported leishmaniasis incidence data in Brazil covering the period between 2001 and 2010 to explore the association of the disease with climatic, environmental, and socioeconomic variables, and to predict its spatial distribution using Bayesian geostatistical models.

Burkholderia pseudomallei is the etiologic agent of melioidosis and classified as a Tier 1 select agent due to the threat of malicious use of the organism. In the face of inherent multidrug resistance new therapeutic strategies are urgently needed to improve patient survival and to protect against a deliberate release. In this article, Dr. Saja Asakrah and colleagues identify the PGE2 pathway as an immunotherapeutic target in pulmonary melioidosis and show that post-exposure COX-2 inhibition provides significant protection against lethal B. pseudomallei lung infection in mice.

New articles published in PLOS Pathogens:

Bacteria have a distinct metabolism, part of which results in the production of bacteria-specific volatile organic compounds (VOCs), which might be used for diagnostic purposes. In this review, Dr. Lieuwe Bos and colleagues argue that goal-targeted studies should be performed to identify potential sets of volatile biological markers and evaluate the diagnostic accuracy of these markers in critically ill patients.

Surveillance data indicate that most circulating A(H1N1)pdm09 influenza viruses have remained antigenically similar since they emerged in humans yet antigenic drift is likely to occur in response to increasing population immunity. Dr. Teagan Guarnaccia and colleagues demonstrate this virus’s ability to undergo rapid antigenic change to evade a low level vaccine response, while remaining fit in a ferret transmission model of immunization and infection.

Malaria is caused by a parasite that grows within red blood cells, eventually rupturing them to release invasive merozoites in a process known as egress. Inhibition of the Plasmodium falciparum cGMP-dependent protein kinase (PfPKG) prevents egress, but the underlying mechanism is unknown. Here Dr. Christine Collins and colleagues clarify egress and show that both malarial PKG and parasite phosphodiesterases are potential targets for new antimalarial drugs.

Category: General, Neglected Diseases | Comments Off

This Week in PLOS Medicine: Integrating Mental Health, Aging & Disability in Malawi, Measuring Maternal & Child Health Coverage, & More.

Image Credit: Flickr Ms. Phoenix

Image Credit: Flickr Ms. Phoenix

This week PLOS Medicine publishes a Collection on measuring maternal and child health coverage, and also continues with the series Integrating Mental Health. Additional works reflect on disability in sub-Saharan Africa, intimate partner violence, and antibiotic stewardship.

In the second article of a five-part series providing a global perspective on integrating mental health, Atif Rahman and colleagues argue that integrating maternal mental health care will help advance maternal and child health. However, many misconceptions about depression in mothers may hamper attempts at integration.

Collin Payne and colleagues investigate development of disabilities and years expected to live with disabilities in participants 45 years and older in Malawi. The researchers show that remaining life spent with severe limitations at age 45 in Malawi is comparable to that of 80-year-olds in the US. In an accompanying Perspective, Andreas Stuck and colleagues offer commentary on aging and disability in Sub-Saharan Africa and discuss next steps for research and policy.

Karen Devries and colleagues conduct a systematic review of longitudinal studies to evaluate the direction of association between symptoms of depression and intimate partner violence. They find that not only are women who have experienced violence from their partner at higher risk of becoming depressed, but women who are depressed may also be at increased risk of experiencing intimate partner violence. In an accompanying Perspective, Alexander Tsai comments on possible public health implications of the study’s insights.

Heiman Wertheim and colleagues describe the launch and impact of VINARES, an initiative to strengthen antimicrobial stewardship in Vietnam. This case study may offer insight for other countries struggling to address the threat of antimicrobial resistance.

The 16-article Collection, Measuring Coverage in Maternal, Newborn, and Child Health, publishes today in PLOS Medicine and PLOS ONE, with an overview by Jennifer Bryce and colleagues. The collection argues that measuring coverage of maternal, newborn and child health in low- and middle-income countries is critical to ensuring that health interventions are reaching the women and children who need them most. Accurate measurement of the effectiveness of those interventions for combating diseases such as pneumonia and malaria, and preventing the transmission of HIV from mother to child, is also deemed essential.

Remember you can comment on, annotate and rate any PLOS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.

Category: General | Tagged , , , , , , , , , , , , , , , , , | Comments Off

Why Should We Care About Measuring Coverage of Maternal, Newborn, and Child Health Interventions?

Jennifer Bryce explains why measuring coverage of maternal, newborn, and child health interventions matters and what we can learn from the new PLOS Collection

Image credit: PLOS

Image Credit: PLOS

Coverage matters!

Coverage matters, because we have interventions that can save the lives of mothers and children in poor countries, but only if they are available, affordable and used. My preoccupation with intervention coverage started in the early 2000s while working in the WHO department that developed the Integrated Management of Childhood Illness (IMCI) strategy.  IMCI brings together numerous life-saving interventions for children, but when we looked at the numbers on how many of the children who needed those interventions were actually getting them, it was horrifying. We had affordable solutions, but they were not reaching enough children, especially in the places with the highest rates of child mortality.

To improve coverage, we need to measure it

Effective action requires sound evidence. If we want to reach the women and children who are not benefitting from health services, we must understand who these families are, and where they live, so that we can devise ways to connect them to the interventions they need. Since 2005, Countdown to 2015 has helped draw attention to gaps in maternal, newborn and child health (MNCH) coverage. Countdown publishes country-by-country profiles of intervention coverage for the countries with the highest rates of mortality, and publicizes the gaps to show what needs to happen — and where — to speed up progress toward the Millennium Development Goals for mothers and children in 2015 and beyond.

But measuring coverage is not easy

Countdown also drew new attention to how we were actually measuring coverage, and the indicators we were using.  Almost all coverage data for MNCH interventions come from one of two global survey programs: the USAID-supported Demographic and Health Surveys (DHS), and the UNICEF-supported Multiple Indicator Cluster Surveys (MICS).  Without these two crucial programs, most governments and their partners would have no data on coverage for their health intervention programs.  But close scrutiny of these survey programs revealed aspects of coverage measurement through household surveys that could be improved.

We can do better

To address these measurement gaps, WHO and UNICEF brought together a group of scientists from around the world through the Child Health Epidemiology Reference Group (CHERG).  CHERG’s mandate is to improve the evidence base across the entire MNCH continuum. The coverage group began by reviewing the state-of-the-art in coverage measurement for all proven interventions tracked by Countdown. We focused our efforts on the highest-impact interventions for which no other group was investigating coverage measurement.
Continue reading »

Category: Collections | Tagged , , , , , , | Comments Off

Female Genital Schistosomiasis (FGS): Sub-Saharan Africa’s Secret Scourge of Girls and Women

PLOS NTDs editor-in-chief Peter Hotez highlights the subject of Female Genital Schistosomiasis in Africa that continues to affect women there heavily, yet receives disproportionally little attention.

Last month, together with Prof. Paul Brindley I wrote about new advances in the study of schistosomiasis caused by Schistosoma haematobium, best known as the cause of urinary tract schistosomiasis and bladder cancer in Africa.  Our article highlighted new animal models, the development of in vitro systems, and the recent completion of the S. haematobium genome leading to recent insights into parasite-induced carcinogenesis.  Compared to the other schistosomes S. haematobium has been relatively neglected by the scientific community in terms of number of citations in the scientific literature, especially since it is the world’s most common schistosome responsible for approximately two-thirds (actually 67%) of the schistosomiasis cases in sub-Saharan Africa where more than 90% of the disease burden occurs.

Mbabazi PS, Andan O, Fitzgerald DW, Chitsulo L, Engels D, et al. (2011) Examining the Relationship between Urogenital Schistosomiasis and HIV Infection. PLoS Negl Trop Dis 5(12): e1396. doi:10.1371/journal.pntd.0001396

Mbabazi PS, Andan O, Fitzgerald DW, Chitsulo L, Engels D, et al. (2011) Examining the Relationship between Urogenital Schistosomiasis and HIV Infection. PLoS Negl Trop Dis 5(12): e1396. doi:10.1371/journal.pntd.0001396

In this and several other articles published in PLOS Neglected Tropical Diseases since 2009 we have tried to consistently emphasize the disproportionate impact of S. haematobium infection on girls and women.  Schistosome eggs embolize to the  uterus, cervix, and lower genital tract of girls and women to form fibrotic nodules known as “sandy patches” that result in a condition known as female genital schistosomiasis (FGS), which is associated with bleeding and pain (especially during sexual intercourse), as well as social stigma and depression.  I have also written about FGS in the lay press.

Some preliminary calculations provide cause for concern about the high prevalence of FGS.  Using the World Health Organization’s conservative estimate of 235 million cases of schistosomiasis or revised estimates from Prof. Charles King of 586-659 million people living with some form of schistosomiasis, and the fact that more than 90% of the global cases occur in sub-Saharan Africa, we can determine that between 200 million and 600 million people suffer from schistosomiasis in sub-Saharan Africa.  Assuming an equal sex distribution these numbers equate to approximately 100-300 million girls and women affected by schistosomiasis.  Using the 67% number for the percentage of cases caused by S. haematobium, there are approximately 67-200 million cases of S. haematobium infection among girls and women.  Further estimates that between 33%% and 75% of girls and women with S. haematobium infection also suffer from FGS in their lower genital tract would indicate that between 20 million and 150 million girls are affected, possibly making FGS one of the most common gynecologic conditions in sub-Saharan Africa where it is a horrific and widespread cause of bleeding, pain, depression, and stigma.
Continue reading »

Category: General, Neglected Diseases | 3 Comments

MSF Scientific Day 2013

Does blogging help patients cope with the lengthy and toxic treatment for multidrug resistant tuberculosis? Do humanitarian responses to crises fail to take sufficient account of the plight of elderly people? Is giving money more effective than giving food supplements to tackle child malnutrition? And will global health expert and Ted Talks alumnus Hans Rosling repeat his sword swallowing routine? These are just a few of the questions that will be answered at the 2013 Médecins Sans Frontières (MSF) Scientific day, screened online live all day from the Royal Society of Medicine, London, UK, on Friday, May 10th.

logo_jpeg_newsite

The agenda is packed with presentations that reflect the diversity of MSF programmes and patients – from examining the experience of bloggers in the MSF TB&Me blog to the use of a cholera vaccine during an outbreak in Guinea to treating tuberculosis in the extremely insecure setting of Somalia. There are innovative tools and approaches, such as seasonal chemoprevention for malaria and large-scale treatment with chelation for thousands of children with severe lead poisoning in northern Nigeria.
Continue reading »

Category: Conference news, General, MSF | Tagged , , , | 1 Comment

This Week in PLOS NTDs and PLOS Pathogens: Tracing the Justinianic Plague; Prudence in Diagnosing Rabies; the Functions of PolyP; Thermal Treatment for Leishmaniasis; and More

ppat.1003331

Caffaro CE, Koshy AA, Liu L, Zeiner GM, Hirschberg CB, et al. (2013) A Nucleotide Sugar Transporter Involved in Glycosylation of the Toxoplasma Tissue Cyst Wall Is Required for Efficient Persistence of Bradyzoites. PLoS Pathog 9(5): e1003331. doi:10.1371/journal.ppat.1003331

The following new articles are publishing in PLOS NTDs this week:

Chronic American cutaneous leishmaniasis is expensive and difficult to treat using conventional techniques that have major adverse side effects. In this paper Dr. Braulio Valencia and colleagues outline a low-cost heat treatment device that produces a therapeutic and stable thermal reaction ranging from 50-54°C. Patients treated during the pilot program experienced cure rates near the standard antimonial treatment.

In this systematic review article Dr. Philippe Carrara and colleagues examine the cases of sixty travelers and expatriates infected with rabies whose origins are from non-endemic nations. Their findings suggest that taking saliva samples and skin biopsies from those visiting rabies-enzootic countries is a prudent precaution, as a diagnosis of viral infection is not always clearly evident.

Exosomes are considered an important route of communication among cells, and depending on various factors these can have distinct effects on recipient cells. In this paper Drs. Kasra Hassani and Martin Olivier describe the effect of leishmania infection and LPS stimulation on protein-content and stimulatory properties of macrophage exosomes. Overall, these results give a deeper understanding of exosome biology and its role in the host-parasite interactions of leishmania.

The following new articles are publishing in PLOS Pathogens this week:

Of the three most devastating pandemics in human history only two have been linked to Yersinia pestis, the bacterium responsible for the plague known as the Black Death. However the first pandemic (the Justinianic Plague), which began in the 6th century is still a matter of controversy. Dr. Harbeck and colleagues detect Y. pestis DNA in samples obtained from multiple 6th century skeletons from Germany confirming that Justinianic Plague affected local populations there.

Polyphosphate (polyP) is a linear polymer found in bacteria, protists and mammalian cells of a few to many hundreds of phosphate (Pi) residues linked by high-energy phosphoanhydride bonds. In this Pearl, Drs. Moreno and Docampo discuss the functions of PolyP, the enzymes involved in PolyP metabolism, and their current role in pathogenesis.

It is widely accepted that the tissue cyst perimeter of Toxoplasma gondii is highly and specifically decorated with glycan modifications; however, the role of these modifications in the establishment and persistence of chronic infection has not been investigated. Dr. Caffaro and colleagues demonstrate for the first time the critical role of parasite glycoconjugates in the persistence of Toxoplasma tissue cysts.

Category: General | Comments Off

Spotlight from the CUGH Conference 2013: Innovative Technologies

I recently attended the Consortium of Universities for Global Health (CUGH) conference in Washington DC from March 13-16, 2013. I found the talks on Innovative Technologies most interesting, in part because technologies have a large impact on the everyday lives of people in developing countries. One technology that Dr. Sasha Kramer, an ecologist from Stanford University, presented was the design and implementation of a new type of compost toilet for use in Haiti, funded by grants and donations. Her idea aims to improve basic sanitation, reduce the risk of diseases like cholera, and create jobs for unemployed Haitians.

Kramer is the executive director and co-founder of the not-for-profit organization Sustainable Organic Integrated Livelihoods (SOIL), which has built more than 50 public composting toilet facilities in Haiti since 2006.  Eighty percent of the population in Haiti does not have access to basic sanitation and existing toilets are not well designed, with human waste flushing straight into rivers or groundwater. In this way the water supply is easily contaminated, and waterborne diseases like cholera are at epidemic levels in Haiti. From the SOIL website: “As of March 4, 2013, cholera has killed 8,057 Haitians and infected nearly 650,000 more. Despite some claims of progress, the epidemic, which was introduced by United Nations troops, has been significantly worse in 2013 than during the same period the year before.”
Continue reading »

Category: Conference news, General | Tagged , , | Comments Off

PLOS Pathogens heads back to Brazil this month for Keystone Symposium on the Innate Immune Response in the Pathogenesis of Infectious Disease!

We are pleased to announce that PLOS Pathogens will be attending the Keystone Symposium on the Innate Immune Response in the Pathogenesis of Infectious Disease at Universidade Ferederal de Ouro Preto (UFOP) in lovely, historical Ouro Preto, MG, Brazil from May 10 -15.

Image credit: Cid Costa Neto

Igreja São Francisco de Paula, Ouro Preto. Image Credit: Cid Costa Neto, Wikimedia Commons

Ricardo Gazzineli, one of PLOS Pathogen’s Associate Editors in the parasitology section, is one of the co-organizers of this meeting.  The meeting will focus on, “the interface of the innate immune system and the microbial pathogens and the role that it plays in protective versus deleterious immune responses and, thereby, of disease outcome.” Scientists from a number of fields will be represented at this symposium, including but not limited to: cell biology, tropical medicine, biochemistry, parasitology, and biotechnology. To learn even more about the symposium, view a video here.

We are happy to be returning to Brazil for this symposium and are very much looking forward to connecting with members of our Editorial Board who will be presenting at the conference as well as meeting numerous attendees and sharing information about the journal. If you are attending this meeting and would like to meet PLOS Pathogens staff, contact us at plospathogens@plos.org or via twitter @PLOSPathogens.

During the symposium, Cory Mann and I (Gina Alvino) will be easy to spot in our PLOS t-shirts and/or buttons, so please do not hesitate to come over and speak with us about the journal! We will be well-supplied with a plethora of informational materials about PLOS Pathogens (in both English and Portuguese) and general PLOS information, as well. As with all other conferences PLOS attends, we will have with us an array of PLOS memorabilia including magnets, buttons and of course, pens!

Throughout the symposium we will be sharing highlights on social media sites such as Twitter and Facebook so that our friends and followers can stay updated. The twitter hashtag for this symposium is #KSimmunity.

Category: General | Tagged , , | Comments Off

Turning the World Upside Down

Isobel Braithwaite shares her thoughts on the recent launch event of the Turning the World Upside Down online platform.

A couple of weeks back, I attended the launch event of the new Turning the World Upside Down (TTWUD) website, which was hosted by Nigel Crisp, ex-chief executive of the UK’s National Health Service and author of a great book of the same name, and organised by Medsin’s director, Jonny Meldrum.  It was a very thought-provoking event, and the site itself is already full of various interesting and unusual case studies from across the world.

TTWUDNear the start of the launch, Paul Farmer (a physician and medical anthropologist who is also the Chair of Harvard’s Department of Global Health, a founding director of the international non-profit Partners In Health, and an all-round inspirational person) made the simple point that global health is basically all about equity.  It’s an often made point, but it can’t be repeated enough.  It’s why I care about global health, and why I first became involved in the student global health network Medsin, focusing mainly on the topic of climate change and health.  Health equity is also under siege right on our doorstep here in the UK, with the current erosion of various safety nets and what sometimes looks rather like wholesale abandonment of the goal of health equity.

Improving global health is also about using and sharing knowledge on what works and to that end, TTWUD seeks to facilitate ‘co-development’ – as Nigel Crisp eloquently puts it – through mutual teaching and learning, by global health professionals and stakeholders from high, low and middle income countries alike.
Continue reading »

Category: Students | Tagged , , , , , , | Comments Off

European Court is on the Wrong Side on Patient Safety

Síle Lane from Sense About Science discusses the recent European Court injunction on clinical trial data.

AllTrials logo for website (2)The European General Court has issued an injunction to prevent the European medicines regulator from releasing information from clinical trials conducted by AbbVie and InterMune at the request of the two companies. While yesterday’s ruling pertains to two particular cases it has ramifications for all.

The Court’s decision puts the European Medicines Agency into conflict with its own policy, announced in 2012, to proactively release data from clinical trials supporting the authorisation of medicines being used by patients all over Europe. The Clinical Study Reports that EMA has made available since last year were one of the few ways that researchers could access otherwise withheld material. Their release was instrumental in spotting serious flaws in the evidence for Roche’s drug Tamiflu, for example, which the UK government alone spent £500m on in one year.

More importantly the Court’s decision at the request of AbbVie and InterMune puts it into conflict with the interests of patients. When GSK joined the AllTrials campaign and promised to publish all the CSRs available since its formation as a company they said that they owe this to the patients who have taken part in their trials. Two hundred other organisations including more than 100 patient groups and 50,000 people have signed up to the campaign calling on regulators worldwide to do everything they can to secure registration and publication of the results of clinical trials.

So we’re on the brink. Patients and researchers all over the world have started pushing for historic change. GSK has shown that it’s not beyond the reach of pharma companies to agree to that change. The EMA has tried going some way to delivering on that change.

But, EMA now has to decide if the European Court’s ruling will divert them from their policy to publish trial information. We will be sending the EMA the AllTrials petition. We will be asking them to continue their fight for transparency and showing them that tens of thousands of people are asking why they don’t have access to the evidence behind the medicines they use, prescribe and research. Will you help us today at www.alltrials.net? Please, ask your colleagues and friends to add their voices and ask them to forward this to others when they have.

The European Court has indicated that it is on the wrong side of history. The EMA now has to show that arguments in favour of secrecy no longer hold.

Síle Lane is director of campaigns at Sense About Science

 

Category: Access, General | Tagged , , , , | 8 Comments